Literature DB >> 31190872

Anti-tumor effect of aloe-emodin on cervical cancer cells was associated with human papillomavirus E6/E7 and glucose metabolism.

Rui Gao1,2, Xiaowen Wu1,3, Zhi Huang1,3, Bi Wang1,4, Fenghu Li5, Hui Xu1,4, Li Ran5.   

Abstract

Background:Aloe-emodin, an anthraquinone present in aloe latex, has been shown to have anti-proliferative properties in cervical cancer disease, all cases of which are almost caused by human papillomavirus (HPV), with the products of E6/E7. It is suggested that aloe-emodin may play an important role in HPV-induced cervical cancer cells. Methods:Hela and SiHa cells were treated with various concentrations of aloe-emodin. MTT assay and flow cytometry were used to identify the cell growth and apoptosis. The expressions of HPV E6, E7 and GLUT1 (glucose transporter-1) were detected by real-time quantitative polymerase chain reaction (qRT-PCR) and Western blot (WB). The glucose uptake, lactate production and ATP production in HeLa and SiHa cells were also investigated. Result:The results indicate that aloe-emodin promoted the apoptosis of HeLa and SiHa cells and decreased the expressions of HPV-related protein E6 and E7. Furthermore, aloe-emodin inhibited glucose metabolism by reducing GLUT1 expression. Overexpression of GLUT1 significantly weakened the apoptosis induced by aloe-emodin in HeLa cells. Conclusion:In this study, we found that aloe-emodin induce apoptosis of cervical cancer cells, which was associated with HPV E6 and E7 and glucose metabolism.

Entities:  

Keywords:  E6/E7; aloe-emodin; cervical cancer; glucose metabolism

Year:  2019        PMID: 31190872      PMCID: PMC6526183          DOI: 10.2147/OTT.S182405

Source DB:  PubMed          Journal:  Onco Targets Ther        ISSN: 1178-6930            Impact factor:   4.147


Introduction

Aloe-emodin (1,8-dihydroxy-3-hydroxymethyl-9,10-anthracenedione, AE), a natural compound from the root and rhizome of Rheum palmatum, has an anti-proliferative effect on different human cancer cell lines. According to previous reports, AE can inhibit invasion of nasopharyngeal carcinoma cells,1 human oral cancer KB cells and hepatocarcinoma cells.2,3 In addition, AE was also worked as a growth inhibitor on cervical cancer cells. Cervical cancer is the most common gynecological malignancies, the incidence of which is the highest in malignant tumor in women and only second to breast cancer worldwide.5,6 Nowadays, the therapies of cervical cancer are mainly surgical treatment, radiotherapy, chemotherapy and other combined treatments.7 Just as other malignant tumors, the factors that affect the survival of patients include poor prognosis, tumor invasion and metastasis in advanced stage.6 Therefore, it is of great importance to explore the effective method for the diagnosis and treatment of cervical cancer. Evidences show that human papillomaviruses (HPVs) infection, the association of which with human cancer was first proposed more than three decades ago by Harald zurHausen,8 is virtually present in all cases of cervical cancer. HPV16 and HPV18 belong to high-risk HPV virus and are the most frequently found types in cervical cancers around the world, accounting for approximately 50% and 20% of the cases, respectively. The products of the early genes in the high-risk mucosal HPV types, E6 and E7, play a key role in HPV-associated cancers.9 Studies have found that there are sustained expressions of viral E6 and E7 proteins in HPV-associated lesions and cancers, which was considered to be the major inducer of cell transformation.10,11 Glucose metabolism provides energy to the process of tumor cells growth.12 Glucose transporter proteins (GLUTs) which mediated glucose uptake is the main carrier. Facilitative glucose transporters transport glucose through the hydrophobic cell membrane along the concentration gradient without energy consumption.13 So far there have been eight kinds of glucose transporter protein (glucouse transporters) identified (Glut1-5 and Glut7-9). GLUT1 is present at variable levels in many tissues and is believed to be responsible for basal glucose uptake.14 Increased GLUT1 expression has been discovered in many cancers, including cervical carcinoma, cervical cancer, lung cancer and colorectal carcinoma.15–18 In this study, in order to explore the potential mechanism of AE on cervical cancer, we investigated the effects of AE on the expressions of HPV E6/E7 and glucose metabolism in HeLa as well as in SiHa cells, finding that AE may promote apoptosis of cervical cancer cells by inhibiting the expressions of HPV E6/E7 and regulating glucose metabolism.

Materials and methods

Cell culture and drug treatment

The human cervical carcinoma cell lines Hela and SiHa were purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). All cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Gibco, Carlsbad, CA, USA) supplement with 10% fetal bovine serum (FBS, Invitrogen, Carlsbad, CA, USA) and 1% penicillin-streptomycin at 37℃ with 5% CO2. 0.1 M AE stock (Sigma) dissolved in dimethyl sulfoxide (DMSO) was diluted into working concentrations by DMEM medium to stimulate cells. The negative control was added with the same volume of DMSO in the culture medium.

Cell transfection

The overexpression of GLUT1 was conducted in accordance with the protocol described previously.19 Briefly, when Hela cells in 6-well plates grew to 60–70% confluence, 4 µg empty pcDNA3.1 vectors or 4 μg pcDNA3.1-GLUT1 were transfected into cells with Lipofectamine 2000 reagent (Invitrogen) in serum-free medium, which was replaced by complete medium containing 10% FBS 5 hrs later. After 2 days, the cells were treated with AE as above mentioned.

MTT assay

MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide] assay was used to measure viable cell growth. 1×105 cells/well were seeded in 96-well plates followed by treating with AE at different doses (10, 20, 50, 100, 200 µM) for 24 hrs. Then, the cells were incubated with the MTT solution for 4 hrs which was dissolved by formazan. Finally, the optical density (OD) values were detected at 550 nm with a Wellscan reader (Labsystems, Santa Fe, NM, USA). The cell proliferation rate was calculated as follows: (ODexperiment/ODcontrol)×100%.20

Cell apoptosis assay by flow cytometry

4×105 Hela and SiHa cells per well were maintained in mediums overnight for adherence and then administrated with AE (50 µM, 100 µM) for 24 hrs. Morphological characteristics of the cells were observed with an inverted microscope. Flow cytometry assay was carried out with an Annexin V-FITC/PI apoptosis detection kit (BD Biosciences) following the manufacturer's instructions.

Western blotting

2×105 cells were lysed with immune-precipitation buffer on ice and centrifugated at 13,000×g for 15 min at 4℃ to collect the supernatant. The lysates were boiled and 40 μg total cell lysates were separated by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), which was transferred onto a polyvinylidene fluoride membrane (Millipore, Bedford, MA, USA). The protein bands were detected by incubating with antibodies including anti-HPV16/18 E6, E7, GLUT1 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), from Boster Bioengineering (Wuhan, China). Enhanced chemiluminescence reagents (Beyotime) was used to visualize the proteins and image J software was applied to measure the relative protein expressions.

Reverse transcription-quantitative PCR (qRT-PCR)

Two micrograms of total RNA, which was extracted from transfected cells using TRIzol reagent (Life Technologies, Carlsbad, CA, USA), was reversed to cDNA with the High-Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA, USA). Real-time PCR was performed with Maxima SYBR Green/ROX qPCR Master Mix (Thermo Scientific, CA, USA) to analyze the gene expression levels and cervical cancer cells replication rate. GAPDH gene was used as an endogenous control. The relative expression values were measured with the 2-ΔΔCt method. The primer sequences were described in Table 1.
Table 1

Sequences of primers for quantitative real-time polymerase chain reaction

PrimerSequences
HPV16-E6Forward5ʹ-CTTACCACAGTTATGCACAGAG-3ʹ
Reverse5ʹ-CTACGTGTTCTTGATGATCTG-3ʹ
HPV16-E7Forward5ʹ-GGAGGATGAAATAGATGGTC-3ʹ
Reverse5ʹ-GTCTTCCAAAGTACGAATGTC-3ʹ
HPV18-E6Forward5ʹ-GACCCTACAAGCTACCTGATC-3ʹ
Reverse5ʹ-GGATTCAACGGTTTCTCTGG-3ʹ
HPV18-E7Forward5ʹ-CTCAGAGGAAGAAAACGATG-3ʹ
Reverse5ʹ-CACAAAGGACAGGGTGTTC-3ʹ
GLUT1Forward5ʹ-CCGCGAATTCATGGATCCCAGCAGCAAGAAG-3ʹ
Reverse5ʹ-CCGCGGATCCTCACACTTGGGAGTCCGCCCC-3ʹ
GAPDHForward5ʹ-GGAGCGAGATCCCTCCAAAAT-3ʹ
Reverse5ʹ-GGCTGTTGTCATACTTCTCATGG-3ʹ
Sequences of primers for quantitative real-time polymerase chain reaction

Glucose metabolism analysis including glucose uptake, lactate and ATP production

HeLa and SiHa cells were starved overnight in serum-free medium and then treated with AE at concentrations of 50 and 100 µM for 0, 4, 8, 12 and 24 h. According to the manufacturers’ instructions, glucose uptake assay was performed with a glucose uptake assay kit (ab136955, Abcam). Lactate production was analyzed using an l-Lactate assay kit (ab65331, Abcam). The measurement of ATP was carried out with an ATP assay kit (ab83355, Abcam). The relative glucose uptake, lactate production and ATP production of AE groups were calculated with the percentage of the DMSO group.

Statistical analysis

All the data were shown as means±SD. The statistical analysis was performed with the SPSS 12.0 software. A value of p<0.05 was considered to be statistically significant.

Results

Effect of AE on cell growth in cervical cancer cells

MTT assay was performed to evaluate the effect of AE on cell growth. Hela and SiHa cells were treated with AE of concentrations from 10 to 200 µM. As shown in Figure 1A, AE obviously inhibited the growth of cells in a concentration-dependent manner. To evaluate the effect of AE on cells’ apoptosis, Hela and SiHa cells were treated with AE at concentrations of 50 and 100 µM for 24 h, displaying that AE remarkedly increased the apoptosis rates in Hela and SiHa cells (Figure 1B).
Figure 1

Effects of AE on cell growth in cervical cancer cells. (A) Anti-proliferative effects of AE in Hela and SiHa cells. Cells were treated with various concentrations of AE and the proliferation measured using the MTT assay. (B) Flow cytometry assay was used to measure the apoptosis rate after treated with AE. *p<0.05 and **p<0.01 compared with the data from the respective control group detected at same time point.

Effects of AE on cell growth in cervical cancer cells. (A) Anti-proliferative effects of AE in Hela and SiHa cells. Cells were treated with various concentrations of AE and the proliferation measured using the MTT assay. (B) Flow cytometry assay was used to measure the apoptosis rate after treated with AE. *p<0.05 and **p<0.01 compared with the data from the respective control group detected at same time point.

Effects of AE on the expression of HPV-16/18 E6 and E7

qRT-PCR and WB analysis were used to identify the mRNA and protein levels of HPV-16/18 E6 and E7 in Hela and SiHa cells after treatment of AE. It was shown that the mRNA levels of HPV18-E6/E7 and HPV16-E6/E7 are inhibited in a concentration-dependent manner in Hela cells (Figure 2A) and in SiHa cells (Figure 2B), respectively. Accordingly, similar results were revealed at protein levels. As shown in Figure 2C–D, protein levels of E6 and E7 were significantly down-regulated in Hela cells and SiHa cells with corresponding quantitative analysis in histogram.
Figure 2

Effects of AE on the expression of HPV-associated genes and proteins. (A–B) The expression of E6 and E7 mRNA were determined using qPCR. (C–D) The protein expression levels of E6 and E7 were determined by WB. *p<0.05, **p<0.01 and ***p<0.001 compared with the data from the respective control group detected at same time point.

Effects of AE on the expression of HPV-associated genes and proteins. (A–B) The expression of E6 and E7 mRNA were determined using qPCR. (C–D) The protein expression levels of E6 and E7 were determined by WB. *p<0.05, **p<0.01 and ***p<0.001 compared with the data from the respective control group detected at same time point.

Effect of AE on glucose metabolism in cervical cancer cells

Malignant cells are known to accelerate metabolism, high glucose requirements, and increased glucose uptake. To evaluate the effect of AE on cell metabolism, glucose uptake, lactate production and ATP production were measured. Hela and siHa cells were treated with AE at concentrations of 50 and 100 µM, showing that AE inhibits metabolism by controlling glucose uptake (Figure 3A), lactate production (Figure 3B) and ATP production (Figure 3C) in a concentration and time-dependent manner.
Figure 3

Effect of AE on glucose metabolism. (A) After treated with AE at a concentration of 50 µml/L and 100 µml/L, the glucose uptake of Hela and SiHa cells decreased. (B) Similarly, lactate production decreased after treated with AE in Hela and SiHa cells. (C) The yield of ATP decreased with the decrease of glucose uptake and lactate production. Glucose metabolism is suppressed in tumor cells. *p<0.05, **p<0.01 and ***p<0.001 compared with the data from the respective control group detected at same time point.

Effect of AE on glucose metabolism. (A) After treated with AE at a concentration of 50 µml/L and 100 µml/L, the glucose uptake of Hela and SiHa cells decreased. (B) Similarly, lactate production decreased after treated with AE in Hela and SiHa cells. (C) The yield of ATP decreased with the decrease of glucose uptake and lactate production. Glucose metabolism is suppressed in tumor cells. *p<0.05, **p<0.01 and ***p<0.001 compared with the data from the respective control group detected at same time point.

AE inhibited glucose metabolism via decreasing GLUT1 expression in cervical cancer cells

Glucose transportion across mammalian cytoplasmic membrane, which is mediated by GLUTs, is the first rate-limiting step in glucose metabolism. Therefore, we hypothesized that the inhibitory effect of AE on tumor metabolism was achieved by adjusting the level of GLUTs. As expected, AE obviously decreased the mRNA level of GLUT1 in HeLa and SiHa cells (Figure 4A–B). Furthermore, the protein expression of GLUT1 was also significantly depressed by AE (Figure 4C–D). However, when GLUT1 was overexpressed in HeLa cells, the inhibitory effects of AE on glucose uptake, lactic production and ATP production were markedly weakened (Figure 5B–D). These results indicated that AE inhibited glucose metabolism via decreasing GLUT1 expression. The transfection efficiency of pcDNA3.1-GLUT1 was evaluated by WB. As shown in Figure 5A, HeLa cells transfected with pcDNA3.1-GLUT1 displayed a much higher GLUT1 level than the cells transfected with pcDNA3.1 vectors.
Figure 4

Effect of AE on the expressions of GLUT1 in cervical cancer cells. (A–B) The relative mRNA expression of GLUT1 was measured by qRT-PCR in Hela and SiHa cells. (C–D) The relative protein expression of GLUT1 was tested by WB, showing a significant depression just like the expression of its mRNA in Hela and SiHa cells. *p<0.05, **p<0.01 and ***p<0.001 compared with the data from the respective control group detected at same time point.

Figure 5

Overexpression of GLUT1 weakened the inhibitory effect of AE on glucose metabolism in HeLa cells. (A) The transfection efficiency of pcDNA3.1-GLUT1 was evaluated by Western blot. pcDNA3.1 vectors were used as negative controls. (B) Overexpression of GLUT1 caused an increase in cell glucose uptake. (C) Lactic production was up-regulated after the overexpression of GLUT1. (D) After overexpression of GLUT1, the production of ATP was also increased.* p<0.05,** p<0.01 and *** p<0.001 compared with the data from the respective control group detected at same time point.

Effect of AE on the expressions of GLUT1 in cervical cancer cells. (A–B) The relative mRNA expression of GLUT1 was measured by qRT-PCR in Hela and SiHa cells. (C–D) The relative protein expression of GLUT1 was tested by WB, showing a significant depression just like the expression of its mRNA in Hela and SiHa cells. *p<0.05, **p<0.01 and ***p<0.001 compared with the data from the respective control group detected at same time point. Overexpression of GLUT1 weakened the inhibitory effect of AE on glucose metabolism in HeLa cells. (A) The transfection efficiency of pcDNA3.1-GLUT1 was evaluated by Western blot. pcDNA3.1 vectors were used as negative controls. (B) Overexpression of GLUT1 caused an increase in cell glucose uptake. (C) Lactic production was up-regulated after the overexpression of GLUT1. (D) After overexpression of GLUT1, the production of ATP was also increased.* p<0.05,** p<0.01 and *** p<0.001 compared with the data from the respective control group detected at same time point.

Overexpression of GLUT1 inhibited the AE-induced apoptosis of cervical cancer cells

MTT assay (Figure 6A) showed that under AE stress, overexpression of GLUT1 significantly promoted the proliferation of HeLa cells compared to the cells transfected with pcDNA3.1 vectors. Flow cytometry assay (Figure 6B and C) displayed that overexpression of GLUT1 obviously decreased the apoptosis induced by AE.
Figure 6

Overexpression of GLUT1 inhibited the apoptosis induced by AE in HeLa cells. (A) Overexpression of GLUT1 caused a dramatic increase in cell proliferation than untreated cells. (B) Overexpressed GLUT1 obviously decreased the apoptosis rate induced by AE. (C) Flow cytometry assay was used to test the apoptosis of HeLa cells. *p<0.05 and **p<0.01 compared with the data from the respective control group detected at same time point.

Overexpression of GLUT1 inhibited the apoptosis induced by AE in HeLa cells. (A) Overexpression of GLUT1 caused a dramatic increase in cell proliferation than untreated cells. (B) Overexpressed GLUT1 obviously decreased the apoptosis rate induced by AE. (C) Flow cytometry assay was used to test the apoptosis of HeLa cells. *p<0.05 and **p<0.01 compared with the data from the respective control group detected at same time point.

Discussion

As a traditional Oriental herb, it has been found that AE has anticancer functions in several cancer cell lines.21,22 More importantly, no obvious toxicity of AE was observed in vivo.21 However, the anticancer molecular mechanisms of AE are still unclear, especially for cervical cancer cells. High-risk human papillomavirus (hrHPV) has been identified as a key factor in the development of cervical cancer.23 HPV-associated cancers are closely related to the persistence of HPV and the accumulation of chromosomal recombination.9 Among the early genes, E6 and E7 are the two most famous oncogenic proteins which are consistently expressed in HPV-associated malignancies and are responsible for the proliferation of cancer cells. Evidence has shown that the expression of E6 and E7 during natural HPV infection could immortalize cells efficiently. However, inhibition of E6 and E7 expression could block the malignant phenotype of cervical cancer cells.7 In the present study, we detected that AE inhibited the proliferation and promoted the apoptosis of Hela and SiHa cells, which was consistent with others’ research. To examine the mechanism responsible for the inhibition of AE on cell growth, WB and PCR were used to identify E6/E7 levels showing that AE significantly decreased the mRNA and protein expressions. These results suggested that the apoptosis of cervical cancer cells induced by AE was related to the expression of E6/E7. Constitutive glucose uptake is a hallmark of cancer cells and provides energy and biosynthetic material for cancer cell proliferation.24 Malignant cells accelerated metabolism and needed more ATP production. It was first observed by Warburg25 that the rate of aerobic glycolysis was increased in cancer cells, which resulted in the accumulation of lactate due to the elevated levels of lactate dehydrogenase converting pyruvate to lactate.26 Moreover, other studies have proposed that tumors use lactate as a fuel, expanding its metabolic functions in cancer.27 We supposed that AE has a suppression on cervical cancer cells by adjusting glucose metabolism. Thus, glucose uptake, lactate production and ATP production were measured in Hela and SiHa cells after treated with AE at doses of 50 and 100 µM, and the result showed that AE indeed inhibited glucose metabolism in a concentration and time-dependent manner. We hypothesized that the inhibitory effect of AE on tumor metabolism was achieved by adjusting the level of GLUT 1. To define whether the restrained metabolism is associated with GLUT1, the expressions of GLUT1 and relative mRNA were measured in Hela and SiHa cells treated with AE. The results showed that the protein level and mRNA level of GLUT1 have a negative correlation with AE in a concentration-dependent manner. In other words, AE inhibits the expression of GLUT1. To further verify the role of GLUT1 in the anti-tumor effect of AE, we overexpressed GLUT1 in Hela cells. As expected, overexpression of GLUT1 not only weakened the inhibitory effects of AE on glucose uptake, lactic production and ATP production, but also decreased the cell apoptosis induced by AE. Taken together, these data demonstrated that AE played an anti-tumor effect through inhibiting glucose metabolism.

Conclusion

In this study, we found that the anti-tumor effect of AE in cervical cancer cells was associated with HPV E6/E7 and glucose metabolism. Research has been reported that overexpressed E6/E7 increased the protein and mRNA levels of GLUT1 in lung cancer cells.28 So, we will further explore the relationship between E6/E7 and GLUT1 in the anti-tumor effect of AE in cervical cancer. What’s more, the anti-tumor effect of AE in vivo was also required to further study.
  28 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  Focus on endometrial and cervical cancer.

Authors:  Lora Hedrick Ellenson; T-C Wu
Journal:  Cancer Cell       Date:  2004-06       Impact factor: 31.743

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

4.  GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy.

Authors:  G Cantuaria; A Fagotti; G Ferrandina; A Magalhaes; M Nadji; R Angioli; M Penalver; S Mancuso; G Scambia
Journal:  Cancer       Date:  2001-09-01       Impact factor: 6.860

5.  Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors.

Authors:  T Pecere; M V Gazzola; C Mucignat; C Parolin; F D Vecchia; A Cavaggioni; G Basso; A Diaspro; B Salvato; M Carli; G Palù
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

Review 6.  Papillomaviruses and cancer: from basic studies to clinical application.

Authors:  Harald zur Hausen
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

7.  Anti-glioma action of aloe emodin: the role of ERK inhibition.

Authors:  S Mijatovic; D Maksimovic-Ivanic; J Radovic; Dj Miljkovic; Lj Harhaji; O Vuckovic; S Stosic-Grujicic; M Mostarica Stojkovic; V Trajkovic
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

Review 8.  Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.

Authors:  Maria L Macheda; Suzanne Rogers; James D Best
Journal:  J Cell Physiol       Date:  2005-03       Impact factor: 6.384

9.  GLUT1 messenger RNA and protein induction relates to the malignant transformation of cervical cancer.

Authors:  Christian Rudlowski; Albert J Becker; Willibald Schroder; Werner Rath; Reinhard Büttner; Markus Moser
Journal:  Am J Clin Pathol       Date:  2003-11       Impact factor: 2.493

10.  Effects of daidzein on estrogen-receptor-positive and negative pancreatic cancer cells in vitro.

Authors:  Jun-Ming Guo; Bing-Xiu Xiao; De-Jian Dai; Qiong Liu; Hong-Hui Ma
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

View more
  8 in total

1.  Antibacterial and Alkali-responsive Cationic Waterborne Polyurethane Based on Modification of Aloe Emodin.

Authors:  Xiaoyan Xiong; Xiaobin Li; Zifan Zhu; Ending Zhang; Jun Shi; Mangeng Lu
Journal:  Chem Res Chin Univ       Date:  2022-08-04       Impact factor: 2.726

Review 2.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.

Authors:  Hua Luo; Chi Teng Vong; Hanbin Chen; Yan Gao; Peng Lyu; Ling Qiu; Mingming Zhao; Qiao Liu; Zehua Cheng; Jian Zou; Peifen Yao; Caifang Gao; Jinchao Wei; Carolina Oi Lam Ung; Shengpeng Wang; Zhangfeng Zhong; Yitao Wang
Journal:  Chin Med       Date:  2019-11-06       Impact factor: 5.455

Review 3.  Aloe and its Effects on Cancer: A Narrative Literature Review.

Authors:  Astère Manirakiza; Laurent Irakoze; Sebastien Manirakiza
Journal:  East Afr Health Res J       Date:  2021-06-11

4.  Emodin sensitizes human pancreatic cancer cells to EGFR inhibitor through suppressing Stat3 signaling pathway.

Authors:  Zhaohong Wang; Hui Chen; Jingjing Chen; Zhong Hong; Yi Liao; Qiyu Zhang; Hongfei Tong
Journal:  Cancer Manag Res       Date:  2019-09-17       Impact factor: 3.989

5.  Integrated analysis of potential pathways by which aloe-emodin induces the apoptosis of colon cancer cells.

Authors:  Dongxiao Jiang; Shufei Ding; Zhujun Mao; Liyan You; Yeping Ruan
Journal:  Cancer Cell Int       Date:  2021-04-27       Impact factor: 5.722

6.  Aloe-emodin inhibits the proliferation, migration, and invasion of melanoma cells via inactivation of the Wnt/beta-catenin signaling pathway.

Authors:  Maotao Du; Pan Shen; Ranjing Tan; Dengyan Wu; Shenghao Tu
Journal:  Ann Transl Med       Date:  2021-12

7.  Emodin exerts antitumor effects in ovarian cancer cell lines by preventing the development of cancer stem cells via epithelial mesenchymal transition.

Authors:  Heming Long; Hongmei Chen; Jun Yan; Haiyan Cheng
Journal:  Oncol Lett       Date:  2022-01-27       Impact factor: 2.967

8.  Phylogeny and polymorphism in the E6 and E7 of human papillomavirus: alpha-9 (HPV16, 31, 33, 52, 58), alpha-5 (HPV51), alpha-6 (HPV53, 66), alpha-7 (HPV18, 39, 59, 68) and alpha-10 (HPV6, 44) in women from Shanghai.

Authors:  Junwei Zhao; Qin Zhan; Junhan Guo; Min Liu; Yetian Ruan; Tailin Zhu; Lingfei Han; Fang Li
Journal:  Infect Agent Cancer       Date:  2019-11-21       Impact factor: 2.965

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.